Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Dr Lal PathLabs posts...

    Dr Lal PathLabs posts Q4 net profit at Rs 31 cr

    Written by Ruby Khatun Khatun Published On 2017-05-15T12:51:52+05:30  |  Updated On 15 May 2017 12:51 PM IST
    Dr Lal PathLabs posts Q4 net profit at Rs 31 cr

    New Delhi: Diagnostic chain Dr Lal PathLabs reported a consolidated net profit of Rs 30.99 crore for the March quarter.


    The company had posted a net profit of Rs 34.44 crore for the corresponding month last year, Dr Lal PathLabs said in a regulatory filing.


    Total income stood at Rs 226.04 crore during the quarter under review as against Rs 203.88 crore in the same period last fiscal.



    For the entire fiscal, the diagnostic chain reported a profit after tax of Rs 154.20 crore. It had posted Rs 132.19 crore PAT in the 2015-16 fiscal.

    The company said its board has recommended a final dividend of Rs 1.70 per share of Rs 10 each for FY2016-17 in addition to the interim dividend of Rs 1.30 paid earlier.


    Shares of Dr Lal PathLabs closed at Rs 900, down 6.60 per cent on BSE.

    diagnostic chainDr Lal PathLabsnet profitprofitprofit after taxRs 154.20 croreRs 226.04 croreRs 30.99 croreRs 34.44 croreTotal income
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok